Since our founding, we have been focusing on building a company with sustainability:
We have generated revenue every year with the goal to be at least operation cash neutral;
We have carefully allocated capital to produce respectable investment return;
We have grown the company organically and continuously to generate product ideas and IP internally;
We have built a portfolio with clear therapeutic focus;
We have built an energetic, dedicated and experienced team who share our vision.
Our vision is to become a fully integrated specialty pharma company, discovering, developing and commercializing our own products in both U.S. and China. We will continue to develop internal capability and technology that are platform based which can be extended to a series of products. We will build both internally and through collaborations with leading academic institutions, discovering capabilities to continue to generate ideas to drive long term growth of the company. We also plan to establish a specialized commercial team to support marketing of our products in U.S. in the areas of epilepsy and dermatology.